Yes. Let's go back to drugs. Are you suggesting we have...?
I've heard a trade negotiator say we should get rid of the 900 people over at Health Canada, have maybe a dozen people looking at what the United States is doing or what other countries are doing, and basing their criteria for drug approvals on that basis.
Are we talking about gutting our regulatory capacity? Is this what it's about?